Search
Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.
Company or person14
EXELIXIS, INC.
Company
Ealixir, Inc.
Company
ENNIS, INC.
Company
Arxis, Inc.
Company
EXAGEN INC.
Company
Novelis Inc.
Company
EXICURE, INC.
Company
CODEXIS, INC.
Company
ESG Inc.
Company
SCYNEXIS INC
Company
Neuraxis, INC
Company
ENTEGRIS INC
Company
EXOZYMES INC.
Company
EXPONENT INC
Company
Primary record7
EXELIXIS, INC. filed 8-K
Item 2.02. Results of Operations and Financial Condition. On October 29, 2026, Exelixis, Inc. (Exelixis) issued a press release announcing its financial results for the quarter ended October 2, 2026, and providing a corp
Quince Therapeutics, Inc. filed 8-K
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On September 30, 2026, each of June Bray, David Lamond and Chr
EXELIXIS, INC. filed 8-K
Item 8.01. Other Events. Today, Exelixis, Inc. (Exelixis) announced that on September 10, 2026, the U.S. Food and Drug Administration (FDA) notified Exelixis that it had extended the review period for Exelixis new drug a
EXELIXIS, INC. filed 8-K
Item 8.01. Other Events. On August 31, 2026, Exelixis, inc. (Exelixis) announced that the U.S. Court of Appeals for the Federal Circuit (Court of Appeals) issued a decision in Exelixis, Inc. v. MSN Laboratories Private L
EXELIXIS, INC. filed SCHEDULE 13D/A
on August 5, 2026. The Shares reported hereby as beneficially owned by the Reporting Persons are held directly by the following investment partnerships, of which the Investment Manager is the investment manager: (i) Fara
EXELIXIS, INC. filed 4
SEC form 4 filed by EXELIXIS, INC. (CIK 939767) on 2026-08-12.
AQR CAPITAL MANAGEMENT LLC filed SCHEDULE 13G/A
0001167557-26-000125.txt : 20260812 SCHEDULE 13G/A 1 primary_doc.xml X0202 SCHEDULE 13G/A 0001167557-26-000047 0001167557 XXXXXXXX LIVE 1 Common Stock, $0.001 Par Value per Share 06/30/2026 0000939767 EXELIXIS, INC. 3016